Market Tracker

07/07 2:51pm ET
40.69
BATS BZX Real-Time Price
As of 11:29am ET
 -1.07 / -2.56%
Today’s Change
18.23
Today|||52-Week Range
42.48
+105.51%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close41.76
Today’s open41.73
Day’s range40.46 - 42.12
Volume67,250
Average volume (3 months)388,094
Market cap$1.4B
Dividend yield--
Data as of 11:13am ET, 07/07/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+32.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio200.8
Price/Sales10.36
Price/Book12.25

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...-0.34-2.78%
RPTPRaptor Pharmaceutica...-0.29-2.10%
ACORAcorda Therapeutics ...-0.28-0.86%
SRPTSarepta Therapeutics...-1.02-3.41%
Data as of 11:29am ET, 07/07/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$0.08
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
Tony J. Hunt
Chief Financial Officer
Jon K. Snodgres
Corporate headquarters
Waltham, Massachusetts

Forecasts